#CLEW MEDICAL SOFTWARE#

Published by Globes, Israel business news - en.il - on January 15, 2020 We are excited to be part of CLEW and look forward to working closely with the company as they deploy their solutions in critical care.'

#CLEW MEDICAL SOFTWARE#

We are pleased to have led this round of funding and look forward working with CLEW as they expand their footprint in the US.'Īntier said, 'Artificial Intelligence and machine learning hold great promise for the healthcare insurance industry. CLEW Medical, a company that specializes in artificial intelligence-powered predictive analytics, has received Food and Drug Administration 510(k) clearance for CLEWICU, the company’s AI-based intensive care unit software that predicts hemodynamic instability in adult patients.

life-threatening complications across various medical care settings. Pitango managing general partner Ittai Harel said, 'CLEW has clearly demonstrated the value that AI can bring to critical care. CLEW provides real-time FDA cleared AI analytics platforms designed to help. We are also delighted to leverage our partnership with Relyens, which is certain to provide strategic value to the company'.

Our innovative analytics engine detects deterioration in real-time and delivers predictive warnings during all phases of a patient’s ICU stay. The latest financing will be used to commercialize CLEW’s platform in the TeleICU and critical care markets.ĬLEW founder and CEO Gal Salomon said, 'We view this round of funding as further validation of our technology and product offering. CLEW Medical (formerly Intensix) mission is to provide healthcare providers and administrators with high-accuracy predictive clinical analytics that improve clinical outcomes and reduce hospital costs. Clew Medical launches AI analytics platformĬLEW's healthcare analytics platform delivers improved clinical and operational outcomes by predicting life-threatening complications and detects deviations from the optimal clinical path.

Clew medical